Enzyme replacement therapy in type I Gaucher disease.
Kay
A C
AC
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037.
Saven
A
A
Garver
P
P
Thurston
D W
DW
Rosenbloom
B F
BF
Beutler
E
E
D000328:Adult; D002648:Child; D002675:Child, Preschool; D005776:Gaucher Disease / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D005962:Glucosylceramidase / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006529:Hepatomegaly / Q000188:drug therapy; D006801:Humans; D037181:Lectins, C-Type; D008264:Macrophages / Q000378:metabolism; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins; D008875:Middle Aged; D010976:Platelet Count; D011956:Receptors, Cell Surface; D011971:Receptors, Immunologic / Q000378:metabolism; D013163:Splenomegaly / Q000188:drug therapy
D006454:Hemoglobins; D037181:Lectins, C-Type; D000090323:Mannose Receptor; D037241:Mannose-Binding Lectins; D011956:Receptors, Cell Surface; D011971:Receptors, Immunologic; D005962:Glucosylceramidase